BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 21607970)

  • 1. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance.
    Auriel E; Regev K; Dori A; Karni A
    Muscle Nerve; 2011 Jun; 43(6):893-4. PubMed ID: 21607970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study.
    Zinman L; Thoma J; Kwong JC; Kopp A; Stukel TA; Juurlink DN
    Muscle Nerve; 2009 Dec; 40(6):947-51. PubMed ID: 19902540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intent to receive influenza A (H1N1) 2009 monovalent and seasonal influenza vaccines - two counties, North Carolina, August 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(50):1401-5. PubMed ID: 20032923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal and H1N1v influenza vaccines in MS: safety and compliance.
    Auriel E; Gadoth A; Regev K; Karni A
    J Neurol Sci; 2012 Mar; 314(1-2):102-3. PubMed ID: 22056469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of an event in the Israeli media on the compliance of patients with influenza vaccinations in the winter of 2006-2007].
    Perlman GY
    Harefuah; 2009 Dec; 148(12):811-4, 856. PubMed ID: 20088431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
    Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
    Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pandemic 2009 influenza H1N1 virus vaccination: compliance and safety in a single hemodialysis center.
    Stavroulopoulos A; Stamogiannos G; Aresti V
    Ren Fail; 2010; 32(9):1044-8. PubMed ID: 20863207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.
    Perdan-Pirkmajer K; Thallinger GG; Snoj N; Čučnik S; Žigon P; Kveder T; Logar D; Praprotnik S; Tomšič M; Sodin-Semrl S; Ambrožič A
    Lupus; 2012 Feb; 21(2):175-83. PubMed ID: 22235050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic.
    Goldfarb I; Panda B; Wylie B; Riley L
    Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S112-5. PubMed ID: 21345408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy.
    Moro PL; Tepper NK; Grohskopf LA; Vellozzi C; Broder K
    Expert Rev Vaccines; 2012 Aug; 11(8):911-21. PubMed ID: 23002972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can influenza H1N1 vaccination lead to the membranous glomerulonephritis?
    Kutlucan A; Gonen I; Yildizhan E; Aydin Y; Sav T; Yildirim U
    Indian J Pathol Microbiol; 2012; 55(2):239-41. PubMed ID: 22771654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination coverage among pregnant women--National 2009 H1N1 Flu Survey (NHFS).
    Ding H; Santibanez TA; Jamieson DJ; Weinbaum CM; Euler GL; Grohskopf LA; Lu PJ; Singleton JA
    Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S96-106. PubMed ID: 21640233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
    Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
    Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of prior or concomitant seasonal influenza vaccination on MF59-adjuvanted H1N1v vaccine (Focetria) in adult and elderly subjects.
    Gasparini R; Schioppa F; Lattanzi M; Barone M; Casula D; Pellegrini M; Veitch K; Gaitatzis N
    Int J Clin Pract; 2010 Mar; 64(4):432-8. PubMed ID: 20039974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women--10 states, 2009-10 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Dec; 59(47):1541-5. PubMed ID: 21124293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of influenza vaccination: Risk-benefit evaluation.
    Wiwanitkit V
    Muscle Nerve; 2010 Aug; 42(2):296; author reply 296. PubMed ID: 20544931
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.
    Loebermann M; Anders G; Brestrich G; Fritzsche C; Klammt S; Boršo D; Frimmel S; Riebold D; Reisinger EC
    Vaccine; 2011 Feb; 29(6):1228-34. PubMed ID: 21167116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.